Follow-up results of a prospective, multicenter, open-label study of oral fludarabine phosphate in patients with previously untreated B-CLL.

被引：0
|
作者：
Rossi, JF
Van Hoof, A
De Boeck, K
Johnson, SA
Bron, D
Foussard, C
Lister, TA
Kramer, MHH
Littlewood, TJ
Marcus, RE
Deconinck, E
Guibon, O
Montillo, M
Tollerfield, SM
机构：
[1] Univ Hosp, Montpellier, France
[2] Acad Hosp St Jan, Brugge, Belgium
[3] Middelheim Hosp, B-2020 Antwerp, Belgium
[4] Musgrove Pk Hosp, Taunton, Somerset, England
[5] Inst Jules Bordet, B-1000 Brussels, Belgium
[6] Univ Hosp, Angers, France
[7] St Bartholomews Hosp, London, England
[8] Meander MC, Amersfoort, Netherlands
[9] Oxford Radcliffe NHS Trust, Oxford, England
[10] Addenbrookes Hosp, Cambridge, England
[11] Univ Hosp, Besancon, France
[12] Hop St Louis, Paris, France
[13] Osped Niguarda Ca Granda, Milan, Italy
[14] Schering Hlth Care, Burgess Hill, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2128.2128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2128
引用
收藏
页码：602A / 602A
页数：1
相关论文
共 50 条
  • [41] Efficacy of infliximab in severe refractory ankylosing spondylitis (AS) results of a 6 months follow-up open-label study.
    Breban, M
    Vignon, E
    Claudepierre, P
    Saraux, A
    Wendling, D
    Lespessailles, E
    Ziegler, LE
    Sibilia, J
    Perdriger, A
    Alexandre, C
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S89 - S89
  • [42] Drisapersen (DRIS) treatment for Duchenne muscular dystrophy (DMD): Results of up to 188 weeks' follow-up of an open-label extension study
    Goemans, N.
    Tulinius, M.
    Wilson, R.
    Wardell, C.
    Bedwell, P.
    Campion, G.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 829 - 829
  • [43] Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a
    Sidonio, Robert F., Jr.
    Thompson, Alexis A.
    Peyvandi, Flora
    Albayrak, Canan
    Yeoh, Seoh Leng
    Lam, Joyce
    Maggiore, Caterina
    Engl, Werner
    Allen, Geoffrey
    Tanada, Srillatha
    BLOOD, 2021, 138
  • [44] EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A
    Peyvandi, F.
    Sidonio, R. F., Jr.
    Stasyshyn, O.
    Alamelu, J.
    Glosli, H.
    Le, P. -Q.
    Albayrak, C.
    Antmen, A. B.
    Lopez, M. Fernandez
    Maggiore, C.
    Engl, W.
    Tangada, S.
    HAEMOPHILIA, 2022, 28 : 48 - 48
  • [45] Design of a phase 3, prospective, multicenter, open-label study of safety and hemostatic efficacy of rurioctocog alfa pegol in previously untreated patients <6 years of age with severe hemophilia A
    Mullins, E.
    Kefurt, C.
    Engl, W.
    Tangada, S.
    HAEMOPHILIA, 2019, 25 : 83 - 83
  • [46] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth N.
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 7 - 8
  • [47] A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation - A preliminary report with 6-month follow-up
    Gruessner, RWG
    Sutherland, DER
    Parr, E
    Humar, A
    Gruessner, AC
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1663 - 1664
  • [48] Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up
    Krepel, Noralie
    Egtberts, Tommy
    Toure-Cuq, Emma
    Bouny, Pierre
    Arns, Martijn
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2022, 47 (01) : 43 - 51
  • [49] Safety and Activity of Lenalidomide and Rituximab in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long-Term Follow-up of an Open-Label Phase II Trial
    Becnel, Melody R.
    Nastoupil, Loretta
    Davis, R. Eric
    Hagemeister, F. B.
    Fanale, Michelle A.
    Fayad, Luis
    Westin, Jason R.
    Wang, Michael
    Oki, Yasuhiro
    Claret, Linda
    Forbes, Sheryl G.
    Feng, Lei
    Samaniego, Felipe
    Neelapu, Sattva S.
    Fowler, Nathan
    BLOOD, 2017, 130
  • [50] Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up
    Noralie Krepel
    Tommy Egtberts
    Emma Touré-Cuq
    Pierre Bouny
    Martijn Arns
    Applied Psychophysiology and Biofeedback, 2022, 47 : 43 - 51
12345